MedPath

Effects of Peas on Blood Glucose Control

Not Applicable
Active, not recruiting
Conditions
Post-prandial Glucose Response
Interventions
Other: Group2
Other: Group1
Registration Number
NCT02552823
Lead Sponsor
St. Boniface Hospital
Brief Summary

Diabetes is one of the most common chronic diseases affecting Canadians (PHAC, 2011). Lifestyle modifications that include a diet high in fibre may lower the risk of developing type 2 diabetes (CDA, 2013). In this context, the presence of fibre in carbohydrate rich foods has been widely recognized for its effect on post-prandial glucose response (PPGR). Peas are high in fibre and protein and show great potential as a functional food. A health claim for PPGR would increase market demand for peas, and help those who want to limit the rise in blood sugar after a meal choose products to meet their goals, but there are several gaps in the literature that need to be filled before a submission to Health Canada can be successful: 1) test foods in appropriate serving sizes; 2) test both the glucose and insulin response; 3) test varieties of peas that that currently available on the market; 4) test whole/split peas (not fractions or isolates); 5) compare peas to appropriate starchy reference food (rice or potato). The proposed study design will address all of these gaps in the current literature and take into consideration Health Canada's guidance document for health claims related to the reduction in PPGR, which sets out the criteria by which the validity of such claims will be assessed.

Specific objectives

1. To determine the effect of 3 common market classes of peas on PPGR and insulin response in a cross-over, randomized, controlled clinical trial.

2. To assess the effect of 3 common market classes of peas on appetite-related sensations using visual analog scales.

3. To demonstrate whether the test and reference products were liked or disliked similarly by participants.

4. To assess any gastrointestinal side effects from eating the test products

Detailed Description

A randomized, controlled, cross-over study designed to examine the PPGR to peas will be conducted at the I.H. Asper Clinical Research Institute in Winnipeg, Manitoba. The study will be divided into 2 groups of 24 healthy volunteers each. In Group 1, eligible participants who have provided consent will be asked to attend 6 clinic visits in a fasted state. Participants will be given white bread at their first and last visits, peas with rice at 3 visits and rice at 1 visit. At each visit participants will provide 7 blood samples via finger poke, 6 questionnaires about their appetite and a questionnaire about the acceptability of the test food. Each visit will last approximately 2.5h and be separated by 3-10 days. Group 2 will undergo the exact same study procedures as group 1, but rice will be replaced with potato.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
64
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
PotatoGroup2Group2, Visit 2-5 Potato (equal to 50g available carbohydrate) given as breakfast to fasting participants
RiceGroup1Group 1, Visit 2-5 Rice (equal to 50g available carbohydrate) given as breakfast to fasting participants
White bread 1Group1Groups 1 and 2, Visit 1 White bread (equal to 50g available carbohydrate) given to fasting participant
White bread 1Group2Groups 1 and 2, Visit 1 White bread (equal to 50g available carbohydrate) given to fasting participant
Pea variety 1 with potatoGroup2Group 2, Visit 2-5 Pea variety 1 with potato (25g available carbohydrate of each) given as breakfast to fasting participants
Pea variety 2 with riceGroup1Group 1, Visit 2-5 Pea variety 2 with rice (25g available carbohydrate of each) given as breakfast to fasting participants
White bread 2Group1Groups 1 and 2, Visit 6 White bread (equal to 50g available carbohydrate) given to fasting participant
Pea variety 1 with riceGroup1Group 1,Visit 2-5 Pea variety 1 with rice (25g available carbohydrate of each) given as breakfast to fasting participants
Pea variety 3 with riceGroup1Group 1, Visit 2-5 Pea variety 3 with rice (25g available carbohydrate of each) given as breakfast to fasting participants
White bread 2Group2Groups 1 and 2, Visit 6 White bread (equal to 50g available carbohydrate) given to fasting participant
Pea variety 2 with potatoGroup2Group 2, Visit 2-5 Pea variety 2 with potato (25g available carbohydrate of each) given as breakfast to fasting participants
Pea variety 3 with potatoGroup2Group 2, Visit 2-5 Pea variety 3 with potato (25g available carbohydrate of each) given as breakfast to fasting participants
Primary Outcome Measures
NameTimeMethod
Postprandial blood insulinup to 2 hours following a meal

samples collected to test insulin at fasting and at 15,30,45,60,90 and 120 minutes after the first bite of the test product

Postprandial blood glucoseup to 2 hours following a meal

samples collected to test glucose at fasting and at 15,30,45,60,90 and 120 minutes after the first bite of the test product

Secondary Outcome Measures
NameTimeMethod
Fullness (Visual analogue scales)up to 2 hours following a meal

Visual analogue scales are administered pre-meal, immediately post-meal and 30, 60, 90 and 120 minutes

Desire to eat (Visual analogue scales)up to 2 hours following a meal

Visual analogue scales are administered pre-meal, immediately post-meal and 30, 60, 90 and 120 minutes

Hunger (Visual analogue scales)up to 2 hours following a meal

Visual analogue scales are administered pre-meal, immediately post-meal and 30, 60, 90 and 120 minutes

Trial Locations

Locations (1)

I. H. Asper Clinical Research Institute

🇨🇦

Winnipeg, Manitoba, Canada

© Copyright 2025. All Rights Reserved by MedPath